Medical prevention of recurrent acute otitis media

An updated overview

Paola Marchisio, Erica Nazzari, Sara Torretta, Susanna Esposito, Nicola Principi

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Acute otitis media (AOM) is one of the most common pediatric diseases; almost all children experience at least one episode, and a third have two or more episodes in the first three years of life. The disease burden of AOM has important medical, social and economic effects. AOM requires considerable financial assistance due to needing at least one doctor visit and a prescription for antipyretics and/or antibiotics. AOM is also associated with high indirect costs, which are mostly related to lost days of work for one parent. Moreover, due to its acute symptoms and frequent recurrences, AOM considerably impacts both the child and family's quality of life. AOM prevention, particularly recurrent AOM (rAOM), is a primary goal of pediatric practice. In this paper, we review current evidence regarding the efficacy of medical treatments and vaccines for preventing rAOM and suggest the best approaches for AOM-prone children.

Original languageEnglish
Pages (from-to)611-620
Number of pages10
JournalExpert Review of Anti-Infective Therapy
Volume12
Issue number5
DOIs
Publication statusPublished - 2014

Fingerprint

Otitis Media
Pediatrics
Medical Economics
Antipyretics
Acute Disease
Prescriptions
Vaccines
Quality of Life
Anti-Bacterial Agents
Costs and Cost Analysis
Recurrence

Keywords

  • acute otitis media
  • antibiotic prophylaxis
  • complementary and alternative medicine
  • otitis media
  • prevention
  • probiotics
  • recurrent acute otitis media
  • vaccine
  • vitamin D
  • xylitol

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology (medical)
  • Microbiology
  • Virology
  • Medicine(all)

Cite this

Medical prevention of recurrent acute otitis media : An updated overview. / Marchisio, Paola; Nazzari, Erica; Torretta, Sara; Esposito, Susanna; Principi, Nicola.

In: Expert Review of Anti-Infective Therapy, Vol. 12, No. 5, 2014, p. 611-620.

Research output: Contribution to journalArticle

@article{9661e69e99cb4570b92d949fce493bee,
title = "Medical prevention of recurrent acute otitis media: An updated overview",
abstract = "Acute otitis media (AOM) is one of the most common pediatric diseases; almost all children experience at least one episode, and a third have two or more episodes in the first three years of life. The disease burden of AOM has important medical, social and economic effects. AOM requires considerable financial assistance due to needing at least one doctor visit and a prescription for antipyretics and/or antibiotics. AOM is also associated with high indirect costs, which are mostly related to lost days of work for one parent. Moreover, due to its acute symptoms and frequent recurrences, AOM considerably impacts both the child and family's quality of life. AOM prevention, particularly recurrent AOM (rAOM), is a primary goal of pediatric practice. In this paper, we review current evidence regarding the efficacy of medical treatments and vaccines for preventing rAOM and suggest the best approaches for AOM-prone children.",
keywords = "acute otitis media, antibiotic prophylaxis, complementary and alternative medicine, otitis media, prevention, probiotics, recurrent acute otitis media, vaccine, vitamin D, xylitol",
author = "Paola Marchisio and Erica Nazzari and Sara Torretta and Susanna Esposito and Nicola Principi",
year = "2014",
doi = "10.1586/14787210.2014.899902",
language = "English",
volume = "12",
pages = "611--620",
journal = "Expert Review of Anti-Infective Therapy",
issn = "1478-7210",
publisher = "Taylor and Francis Ltd.",
number = "5",

}

TY - JOUR

T1 - Medical prevention of recurrent acute otitis media

T2 - An updated overview

AU - Marchisio, Paola

AU - Nazzari, Erica

AU - Torretta, Sara

AU - Esposito, Susanna

AU - Principi, Nicola

PY - 2014

Y1 - 2014

N2 - Acute otitis media (AOM) is one of the most common pediatric diseases; almost all children experience at least one episode, and a third have two or more episodes in the first three years of life. The disease burden of AOM has important medical, social and economic effects. AOM requires considerable financial assistance due to needing at least one doctor visit and a prescription for antipyretics and/or antibiotics. AOM is also associated with high indirect costs, which are mostly related to lost days of work for one parent. Moreover, due to its acute symptoms and frequent recurrences, AOM considerably impacts both the child and family's quality of life. AOM prevention, particularly recurrent AOM (rAOM), is a primary goal of pediatric practice. In this paper, we review current evidence regarding the efficacy of medical treatments and vaccines for preventing rAOM and suggest the best approaches for AOM-prone children.

AB - Acute otitis media (AOM) is one of the most common pediatric diseases; almost all children experience at least one episode, and a third have two or more episodes in the first three years of life. The disease burden of AOM has important medical, social and economic effects. AOM requires considerable financial assistance due to needing at least one doctor visit and a prescription for antipyretics and/or antibiotics. AOM is also associated with high indirect costs, which are mostly related to lost days of work for one parent. Moreover, due to its acute symptoms and frequent recurrences, AOM considerably impacts both the child and family's quality of life. AOM prevention, particularly recurrent AOM (rAOM), is a primary goal of pediatric practice. In this paper, we review current evidence regarding the efficacy of medical treatments and vaccines for preventing rAOM and suggest the best approaches for AOM-prone children.

KW - acute otitis media

KW - antibiotic prophylaxis

KW - complementary and alternative medicine

KW - otitis media

KW - prevention

KW - probiotics

KW - recurrent acute otitis media

KW - vaccine

KW - vitamin D

KW - xylitol

UR - http://www.scopus.com/inward/record.url?scp=84898940477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898940477&partnerID=8YFLogxK

U2 - 10.1586/14787210.2014.899902

DO - 10.1586/14787210.2014.899902

M3 - Article

VL - 12

SP - 611

EP - 620

JO - Expert Review of Anti-Infective Therapy

JF - Expert Review of Anti-Infective Therapy

SN - 1478-7210

IS - 5

ER -